- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04233710
Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy (RoboCP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The defining feature of hemiparetic cerebral palsy is motor impairments primarily on one side of the body. Robotic rehabilitation and non-invasive brain stimulation are both emerging technologies that may be beneficial in improving motor performance in individuals with hemiparetic cerebral palsy. Robotic rehabilitation can allow for hundreds of arm movements in the span of an hour, a level of concentrated repetitions that is not possible in traditional rehabilitation. Additionally, robotics can target specific deficits, such as coordinating both arms together, improving accuracy of reaching movements, or improving proprioception, while simultaneously giving the therapist and patient quantitative feedback on performance. Non-invasive brain stimulation using transcranial direct current stimulation (tDCS) can safely modulate activity in regions of the brain and has emerged as a tool to enhance motor learning in typically developing children and augment therapy in children with hemiparetic cerebral palsy.
Children with hemiparetic cerebral palsy will be randomized to receive robotic rehabilitation with tDCS or robotic rehabilitation with sham-tDCS. Participants and the assessors will be blinded to the treatment. All children will complete 10 sessions within 3 weeks of 1.5 hours of robotic rehabilitation. The Kinarm Exoskeleton Robot will be used and children will play games with their affected arm or both arms to target different aspects of sensorimotor control. Children will simultaneously receive real or sham tDCS for the first 20 minutes of the session. tDCS will consist of 1 mA current with the cathode applied over the contralesional M1 area. All children will be assessed before and after the 10 session intervention period using robotic and clinical measures of motor and sensory performance, and at a 3 month follow up.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T3B 6A8
- Recruiting
- Alberta Children's Hospital
-
Contact:
- Rachel L Hawe, DPT, PhD
- Phone Number: 403-944-1094
- Email: rachel.hawe@ucalgary.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- confirmed diagnosis of hemiparetic cerebral palsy due to unilateral perinatal stroke
- age 6-18 years
- Manual Ability Classification System (MACS) Level I-III
- Modified Ashworth Score in shoulder and elbow <=3;
- Visual acuity (corrected) better than 20/50 in both eyes
- able to follow instructions and comply with protocol;
- able to give consent/assent;
- able to commit to all assessment and intervention sessions.
Exclusion Criteria:
- significant contractures in the upper extremity;
- other neurological conditions or active medical disease;
- unstable epilepsy;
- contraindications to tDCS;
- botulinum toxin A injections in the upper extremity in the past 6 months;
- upper extremity surgical intervention in past 6 months;
- involvement in another interventional study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Robot + tDCS
10 sessions of 1.5 hrs of robotic therapy within a 3 week period, with 20 minutes of 1mA cathodal tDCS applied to the contralesional M1 area during first 20 minutes of robotic therapy.
Robotic therapy will be conducted using the Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.
|
Robotic therapy with Kinarm Exoskeleton Robot and 1 mA cathodal tDCS applied to contralesional M1 for 20 minutes.
|
|
Sham Comparator: Robot + sham tDCS
10 sessions of 1.5 hrs of robotic therapy within a 3 week period with 20 minutes of SHAM tDCS applied during the first 20 minutes of the robotic therapy.
As with experimental arm, electrode will be placed on contralesional M1.
Current will ramp up and then immediately ramp down to simulate the cutaneous sensations felt with actual tDCS.
Robotic therapy will be delivered with Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.
|
Robotic therapy with Kinarm Exoskeleton Robot and sham tDCS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reaching Accuracy
Time Frame: change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
Change in reaching accuracy as measured by initial direction error on robotic visually guided reaching task.
|
change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standardized robotic measures of motor and sensory performance
Time Frame: change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
Robotic measures of spatiotemporal reaching (path length ratio, reaction time, movement speed, number of speed maximums), proprioception (variability in position matching) and bilateral object hitting task (number of balls hit with each hand).
Each measure will be assessed as change from pre-assessment to immediate post-assessment
|
change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
|
Assisting Hand Assessment
Time Frame: change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
Performance on clinical assessment that determines how effectively the affected limb is used on tasks typically requiring both arms.
|
change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
|
Box and Block Assessment
Time Frame: change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
Measure of ability to reach, grasp and release that measures how many 1" cubes a child can move from one side of a box to another in 1 minute.
|
change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
|
Purdue Pegboard
Time Frame: change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
Measure of manual dexterity measured by how many small pegs a child can place in a pegboard in 30 seconds.
|
change between pre-assessment (within 1 week of starting intervention) and post-assessment (within 1 week of completing intervention)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sean P Dukelow, MD, PhD, University of Calgary
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB17-1008
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemiplegic Cerebral Palsy
-
Cairo UniversityActive, not recruitingHemiplegic Cerebral PalsyEgypt
-
Riphah International UniversityRecruitingHemiplegic Cerebral PalsyPakistan
-
Cairo UniversityCompletedCerebral Palsy Spastic HemiplegicEgypt
-
Cairo UniversityActive, not recruitingCerebral Palsy Spastic HemiplegicEgypt
-
Holland Bloorview Kids Rehabilitation HospitalCanadian Institutes of Health Research (CIHR)RecruitingCerebral Palsy (CP) | Hemiplegic Cerebral PalsyCanada
-
Suleyman Demirel UniversityCompletedCerebral Palsy | Hemiplegic Cerebral Palsy | Spastic Diplegia Cerebral PalsyTurkey (Türkiye)
-
Ankara UniversityCompleted
-
University of LeedsRecruiting
-
Istanbul UniversityRecruitingExercise | Cerebral Palsy (CP) | Hemiplegic Cerebral Palsy | Balance | Functional Mobility | Core StabilizationTurkey (Türkiye)
-
Cairo UniversityCompletedLung Boost Trainer Versus Incentive Spirometer in Post COVID-19 Hemiplegic CP Children (COVID-19 CP)CP (Cerebral Palsy) | Post Covid-19 | HemiplegicEgypt
Clinical Trials on Robot Rehabilitation + tDCS
-
National Rehabilitation Center, Seoul, KoreaUnknown
-
National Rehabilitation Center, Seoul, KoreaUnknown
-
Auxilium Vitae VolterraCompleted
-
National Rehabilitation Center, Seoul, KoreaUnknown
-
National Rehabilitation Center, Seoul, KoreaRecruitingStrokeKorea, Republic of
-
Chinese University of Hong KongRecruiting
-
Poznan University of Medical SciencesEGZOTech sp. z o.o.; Szpital Wojewódzki w PoznaniuRecruitingPost-Viral Fatigue SyndromePoland
-
University Hospital of FerraraCompleted
-
Universiti Teknologi MalaysiaNational Stroke Association of Malaysia (NASAM); Collaborative Research in... and other collaboratorsCompleted